Metraipolis › archive › dc_4fe01c48cf25

Dose rounding of trastuzumab deruxtecan in chinese patients: cost savings and safety outcomes in real-world study — Europe PMC PMID:42376667

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42376667
DOI
10.3389/fonc.2026.1868388
License (as archived)
solo-consultazione
Archived
2026-10-31T11:18:41.597Z
SHA-256 of the archived text
151fed53d674580c6da473d867f18423fc6dc38919fffb0e08768e10633bf50b
Stable URL of this page
https://metraipolis.com/documento/dc_4fe01c48cf25

How to cite

Dose rounding of trastuzumab deruxtecan in chinese patients: cost savings and safety outcomes in real-world study — Europe PMC PMID:42376667 — Europe PMC (en), https://europepmc.org/article/MED/42376667 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4fe01c48cf25 (Metraipolis archive dc_4fe01c48cf25, sha256 151fed53d674580c6da473d867f18423fc6dc38919fffb0e08768e10633bf50b)
BibTeX
@misc{dc4fe01c48cf25,
  title = {Dose rounding of trastuzumab deruxtecan in chinese patients: cost savings and safety outcomes in real-world study — Europe PMC PMID:42376667},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42376667},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4fe01c48cf25; sha256 151fed53d674580c6da473d867f18423fc6dc38919fffb0e08768e10633bf50b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42376667. Agents can read the archived copy with the MCP tool read_document.